Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AI pharmaceutical company Generate Biomedicines (GENB.US) sets IPO price at $16 per share, to be listed on Nasdaq tonight

AI pharmaceutical company Generate Biomedicines (GENB.US) sets IPO price at $16 per share, to be listed on Nasdaq tonight

老虎证券老虎证券2026/02/27 07:16
Show original
This biotechnology company, currently in Phase III clinical trials, issued 25 million shares at $16 per share (the midpoint of the $15 to $17 price range), successfully raising $400 million.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs: Applied Materials (AMAT.US) Posts Solid Q4 Results, DRAM and Advanced Packaging to Drive Accelerated Growth by 2027

Goldman Sachs maintains its "Buy" rating on Applied Materials but lowers its 12-month target price from $670 to $580.

智通财经•2026/11/13 09:18
Goldman Sachs: Applied Materials (AMAT.US) Posts Solid Q4 Results, DRAM and Advanced Packaging to Drive Accelerated Growth by 2027